SUBSCRIBE
SUBSCRIBE

Trace Neuroscience

NEWS
Solution Concept with Handshake on Chalkboard Background
NextGen
Trace Unites ALS Teams Behind a Target That Could Broaden Treatment Access
Trace Neuroscience, a member of BioSpace’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims to bring more treatment options to the ALS community.
March 25, 2026
 · 
3 min read
 · 
Annalee Armstrong
NextGen
BioSpace’s NextGen Class of 2026 Attracts Big Bucks From Tight Wallets
From biotech veterans to embattled modalities to a new wave of RNAi therapeutics, BioSpace’s NextGen Class of 2026 emerged during a tough fundraising environment in 2025. Check out the 15 battle-tested companies that caught our eye.
January 7, 2026
 · 
2 min read
 · 
Annalee Armstrong
IN THE PRESS
Press Releases
Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board
February 16, 2026
 · 
9 min read
Press Releases
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
April 1, 2025
 · 
3 min read
Press Releases
Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
November 12, 2024
 · 
5 min read
AWARDS
  • NextGen Class of 2026 Badge
JOBS